The article discusses a groundbreaking study on Alzheimer's disease, highlighting the role of the ApoE4 gene in vascular damage leading to Alzheimer's. The study, funded by the Alzheimer's Association, The Jeffrey Epstein VI Foundation, and others, reveals how ApoE4 increases cyclophilin A, causing inflammation and damage to the blood-brain barrier. This research suggests a vascular origin for Alzheimer's, alongside the traditionally implicated amyloid beta protein. Jeffrey Epstein's foundation supports this research, emphasizing the potential for new therapeutic targets.
documents/EFTA01084918.pdf
{}